FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/14/2026
Back to search
Official data from USPTO
HEKETISS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEKETISS
ST13
US500000079432899Class
1, 3, 5
Filing
79432899
Registration
8209050
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
07/14/2026
Trademark type
Word
Nice classes
1, 3, 5
Filing date
06/17/2025
Registration date
04/14/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2026
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
CH
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
HEKETISS SA
Representatives
Andrea L. Hintz Resonate IP, LLC
Technical classification
Nice Classes
Class 1Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells other than for medical or veterinary use; stem cells for scientific use; culture media for growing cells for scientific and research purposes
Class 3
Non-medicated toiletry preparations and cosmetic products in the nature of cosmetic preparations for skinhair and scalp care; cosmetic preparations for skin regeneration; cosmetic gelscreamslotionsserumsbalmspomadesoilsemulsionsfoamsfor skin care; beauty milks; skin masks; non-medicated anti-aging skin care preparations
Class 5
Pharmaceutical productsmedical and veterinary preparationspharmaceutical preparations for treating skin wounds and diseases; pharmaceutical products for human usepharmaceutical preparations for use in dermatology; pharmacological being pharmaceutical preparations for skin care; pharmaceutical products for veterinary usepharmaceutical preparations for treating skin wounds and diseases; bandages for skin wounds; wound dressings; stem cells for medical use; surgical implants grown from stem cells being surgical implants comprising living tissue; living cells for medical use; biological preparations for medical and therapeutic usefor the treatment of skin disorders; biological tissue intended for subsequent implantation; medicated solutions being pharmaceutical preparations for tissue regeneration; medicated solutions being pharmaceutical preparations for skin regeneration; medicated cleansers for the skin and wounds
Publications
History of USPTO decisions and trademark events.
19 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/14/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/24/2026
PUBO
PUBLISHED FOR OPPOSITION
02/24/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/15/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2026
RFNT
REFUSAL PROCESSED BY IB
01/01/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/18/2025
RFRR
REFUSAL PROCESSED BY MPU
12/18/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/08/2025
CNRT
NON-FINAL ACTION WRITTEN
11/07/2025
DOCK
ASSIGNED TO EXAMINER
11/04/2025
MAFR
APPLICATION FILING RECEIPT MAILED
09/22/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/18/2025
Continuous trademark protection
Get notified about every new filing that threatens HEKETISS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.